methyl N-[[1-(3-fluoro-4-morpholin-4-ylphenyl)triazol-4-yl]methyl]carbamodithioate

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 恶嗪烷类
• 英文名称: methyl N-[[1-(3-fluoro-4-morpholin-4-ylphenyl)triazol-4-yl]methyl]carbamodithioate
• 化学式: C₁₅H₁₈FN₅OS₂
• 分子量: 367.5
• InChiKey: WAUHUKQZUSDTLI-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  24
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  113
• 氢给体数：
  1
• 氢受体数：
  7

文献信息

• NOVEL ANTIBACTERIAL COMPOUNDS: PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
  申请人：Das Jagattaran

  公开号：US20050113347A1

  公开（公告）日：2005-05-26

  The present invention relates to novel triazole compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them. More particularly, the present invention relates to novel triazoles of the general formula (I) their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

  本发明涉及一种新型三唑化合物，其化学式为（I），其衍生物，类似物，互变异构体，区域异构体，旋转异构体，立体异构体，多晶形态，药学上可接受的盐，药学上可接受的溶剂化合物以及含有它们的制药组合物。更具体地，本发明涉及一种新型三唑化合物，其一般式为（I），其衍生物，类似物，互变异构体，区域异构体，旋转异构体，立体异构体，多晶形态，药学上可接受的盐，药学上可接受的溶剂化合物以及含有它们的制药组合物。
• Novel antibacterial compounds: process for their preparation and pharmaceutical compositions containing them
  申请人：Das Jagattaran

  公开号：US20050209223A1

  公开（公告）日：2005-09-22

  The present invention relates to novel triazole compounds of formula (I), their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them. More particularly, the present invention relates to novel triazoles of the general formula (I) their derivatives, their analogs, their tautomeric forms, their regioisomers, their rotamers, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutical compositions containing them.

  本发明涉及公式（I）的新型三唑类化合物及其衍生物、类似物、互变异构体、区域异构体、旋转异构体、立体异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂化物和含有它们的制药组合物。更特别地，本发明涉及一般公式（I）的新型三唑及其衍生物、类似物、互变异构体、区域异构体、旋转异构体、立体异构体、多晶形态、药学上可接受的盐、药学上可接受的溶剂化物和含有它们的制药组合物。
• NOVEL ANTIBACTERIAL COMPOUNDS:PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
  申请人：Dr. Reddy's Laboratories Ltd.

  公开号：EP1467977A1

  公开（公告）日：2004-10-20
• US6914058B2
  申请人：——

  公开号：US6914058B2

  公开（公告）日：2005-07-05
• US7202254B2
  申请人：——

  公开号：US7202254B2

  公开（公告）日：2007-04-10